{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,11,4]],"date-time":"2022-11-04T00:17:12Z","timestamp":1667521032163},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,1,30]],"date-time":"2019-01-30T00:00:00Z","timestamp":1548806400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1007\/s00105-019-4360-5","type":"journal-article","created":{"date-parts":[[2019,1,30]],"date-time":"2019-01-30T08:06:21Z","timestamp":1548835581000},"page":"215-227","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Merkelzellkarzinom"],"prefix":"10.1007","volume":"70","author":[{"given":"Christina","family":"Drusio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00fcrgen C.","family":"Becker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirk","family":"Schadendorf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Selma","family":"Ugurel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,1,30]]},"reference":[{"key":"4360_CR1","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1001\/archderm.1972.01620040075020","volume":"105","author":"C Toker","year":"1972","unstructured":"Toker C (1972) Trabecular carcinoma of the skin. Arch Dermatol 105:107\u2013110","journal-title":"Arch Dermatol"},{"key":"4360_CR2","doi-asserted-by":"publisher","first-page":"17077","DOI":"10.1038\/nrdp.2017.77","volume":"3","author":"JC Becker","year":"2017","unstructured":"Becker JC, Stang A, DeCaprio JA et\u00a0al (2017) Merkel cell carcinoma. Nat Rev Dis Primers 3:17077. https:\/\/doi.org\/10.1038\/nrdp.2017.77","journal-title":"Nat Rev Dis Primers"},{"key":"4360_CR3","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.ejca.2016.10.022","volume":"71","author":"D Schadendorf","year":"2017","unstructured":"Schadendorf D, Lebb\u00e9 C, zur Hausen A, Avril M\u2011F, Hariharan S, Bharmal M, Becker JC (2017) Merkel cell carcinoma: Epidemiology, prognosis, therapy and unmet medical needs. Eur J Cancer 71:53\u201369","journal-title":"Eur J Cancer"},{"key":"4360_CR4","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ejca.2018.02.003","volume":"94","author":"A Stang","year":"2018","unstructured":"Stang A, Becker JC, Nghiem P, Ferlay J (2018) The association between geographic location and incidence of Merkel cell carcinoma in comparison to melanoma: an international assessment. Eur J Cancer 94:47\u201360. https:\/\/doi.org\/10.1016\/j.ejca\u00a0.2018.02.003","journal-title":"Eur J Cancer"},{"key":"4360_CR5","doi-asserted-by":"crossref","unstructured":"Cook DL et\u00a0al Merkel cell carcinoma: a\u00a0review and update on current concepts. Diagn Histopathol 2010;22(4):127\u2013133","DOI":"10.1016\/j.mpdhp.2016.04.002"},{"key":"4360_CR6","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1111\/jdv.13698","volume":"30","author":"O Zaar","year":"2016","unstructured":"Zaar O, Gillstedt M, Lindel\u00f6f B, Wennberg-Lark A\u2011M, Paoli J (2016) Merkel cell carcinoma incidence is increasing in Sweden. J Eur Acad Dermatol Venereol 30:1708\u20131713","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"4360_CR7","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1111\/php.12687","volume":"93","author":"R Prasad","year":"2017","unstructured":"Prasad R, Katiyar SK (2017) Crosstalk among UV-induced inflammatory mediators, DNA damage and epigenetic regulators facilitates suppression of the immune system. Photochem Photobiol 93:930\u2013936","journal-title":"Photochem Photobiol"},{"key":"4360_CR8","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1158\/1055-9965.EPI-05-0895","volume":"15","author":"RA Howard","year":"2006","unstructured":"Howard RA, Dores GM, Curtis RE, Anderson WF, Travis LB (2006) Merkel cell carcinoma and multiple primary cancers. Cancer Epidemiol Biomarkers Prev 15:1545\u20131549","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"4360_CR9","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(02)07668-7","volume":"359","author":"EA Engels","year":"2002","unstructured":"Engels EA, Frisch M, Goedert JJ, Biggar RJ, Miller RW (2002) Merkel cell carcinoma and HIV infection. Lancet 359:497\u2013498","journal-title":"Lancet"},{"key":"4360_CR10","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1001\/jamadermatol.2016.4920","volume":"153","author":"GL Garrett","year":"2017","unstructured":"Garrett GL et\u00a0al (2017) Incidence of and risk factors for skin cancer in organ transplant recipients in the United States. JAMA Dermatol 153:296\u2013303","journal-title":"JAMA Dermatol"},{"key":"4360_CR11","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/bjc.2016.391","volume":"116","author":"H Sahi","year":"2017","unstructured":"Sahi H et\u00a0al (2017) History of chronic inflammatory disorders increases the risk of Merkel cell carcinoma, but does not correlate with Merkel cell polyomavirus infection. Br J Cancer 116:260\u2013264","journal-title":"Br J Cancer"},{"key":"4360_CR12","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1126\/science.1152586","volume":"319","author":"H Feng","year":"2008","unstructured":"Feng H, Shuda M, Chang Y, Moore PS (2008) Clonal integration of a\u00a0polyomavirus in human Merkel cell carcinoma. Science 319:1096\u20131100","journal-title":"Science"},{"key":"4360_CR13","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/cup.12860","volume":"44","author":"J Sparks","year":"2017","unstructured":"Sparks J, Sparks M, Malone JC (2017) Cutaneous Merkel cell carcinoma: multiple asynchronous primary lesions in a\u00a0patient on immunosuppressive therapy. J\u00a0Cutan Pathol 44:309\u2013312","journal-title":"J. Cutan. Pathol."},{"key":"4360_CR14","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ad.2016.07.021","volume":"108","author":"B Llombart","year":"2017","unstructured":"Llombart B, Kindem S, Chust M (2017) Merkel cell carcinoma: an update of key imaging techniques, prognostic factors, treatment, and follow-up. Actas Dermosifiliogr 108:98\u2013107","journal-title":"Actas Dermosifiliogr"},{"issue":"Suppl. 3","key":"4360_CR15","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/ddg.12015_6","volume":"11","author":"JC Becker","year":"2013","unstructured":"Becker JC et\u00a0al (2013) Brief S2k guidelines\u2014Merkel cell carcinoma. Junge Dtsch Dermatol Ges 11(Suppl. 3):29\u201336","journal-title":"Junge Dtsch Dermatol Ges"},{"key":"4360_CR16","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.jaad.2010.02.056","volume":"63","author":"BD Lemos","year":"2010","unstructured":"Lemos BD et\u00a0al (2010) Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: analysis of 5823 cases as the basis of the first consensus staging system. J\u00a0Am Acad Dermatol 63:751\u2013761","journal-title":"J. Am. Acad. Dermatol."},{"key":"4360_CR17","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/bjd.14240","volume":"174","author":"DA Gunaratne","year":"2016","unstructured":"Gunaratne DA, Howle JR, Veness MJ (2016) Sentinel lymph node biopsy in Merkel cell carcinoma: a\u00a015-year institutional experience and statistical analysis of 721 reported cases. Br J Dermatol 174:273\u2013281","journal-title":"Br. J. Dermatol."},{"key":"4360_CR18","doi-asserted-by":"publisher","first-page":"3564","DOI":"10.1245\/s10434-016-5266-4","volume":"23","author":"KL Harms","year":"2016","unstructured":"Harms KL, Healy MA, Nghiem P et\u00a0al (2016) Ann Surg Oncol 23:3564. https:\/\/doi.org\/10.1245\/s10434-016-5266-4","journal-title":"Ann Surg Oncol"},{"key":"4360_CR19","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1097\/DSS.0000000000000801","volume":"42","author":"L Kline","year":"2016","unstructured":"Kline L, Coldiron B (2016) Mohs micrographic surgery for the treatment of Merkel cell carcinoma. Dermatol Surg 42:945\u2013951","journal-title":"Dermatol. Surg."},{"key":"4360_CR20","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1093\/annonc\/mdw035","volume":"27","author":"A Servy","year":"2016","unstructured":"Servy A et al (2016) Merkel cell carcinoma: value of sentinel lymph-node status and adjuvant radiation therapy. Ann Oncol 27:914\u2013919","journal-title":"Ann Oncol"},{"key":"4360_CR21","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1016\/j.ejca.2015.06.131","volume":"51","author":"C Lebbe","year":"2015","unstructured":"Lebbe C et al (2015) Diagnosis and treatment of Merkel Cell Carcinoma. European consensus-based interdisciplinary guideline. Eur J Cancer 51:2396\u20132403","journal-title":"Eur J Cancer"},{"key":"4360_CR22","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1002\/cam4.815","volume":"5","author":"JG Iyer","year":"2016","unstructured":"Iyer JG et\u00a0al (2016) Response rates and durability of chemotherapy among 62 patients with metastatic Merkel cell carcinoma. Cancer Med 5:2294\u20132301","journal-title":"Cancer Med"},{"key":"4360_CR23","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.19218","author":"JC Becker","year":"2017","unstructured":"Becker JC et al (2017) Evaluation of real-world treatment outcomes in patients with distant metastatic Merkel cell carcinoma following second-line chemotherapy in Europe. Oncotarget. https:\/\/doi.org\/10.18632\/oncotarget.19218","journal-title":"Oncotarget"},{"issue":"10","key":"4360_CR24","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1016\/S1470-2045(16)30364-3","volume":"17","author":"HL Kaufman","year":"2016","unstructured":"Kaufman HL, Russell J, Hamid O et al (2016) Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a\u00a0multicentre, single-group, open-label, phase 2 trial. Lancet Oncol 17(10):1374\u20131385. https:\/\/doi.org\/10.1016\/S1470-2045(16)30364-3","journal-title":"Lancet Oncol"},{"key":"4360_CR25","doi-asserted-by":"publisher","unstructured":"Topalian L et al Abstract CT074: Non-comparative, open-label, multiple cohort, phase 1\/2 study to evaluate nivolumab (NIVO) in patients with virus-associated tumors (CheckMate 358): Efficacy and safety in Merkel cell carcinoma (MCC). Cancer Res 2017;77:CT74\u2013CT74. https:\/\/doi.org\/10.1158\/1538-7445.AM2017-CT074","DOI":"10.1158\/1538-7445.AM2017-CT074"},{"issue":"26","key":"4360_CR26","doi-asserted-by":"publisher","first-page":"2542","DOI":"10.1056\/NEJMoa1603702","volume":"374","author":"PT Nghiem","year":"2016","unstructured":"Nghiem PT, Bhatia S, Lipson EJ et al (2016) PD-1 blockade with pembrolizumab in advanced Merkel-cell carcinoma. N\u00a0Engl J Med 374(26):2542\u20132552. https:\/\/doi.org\/10.1056\/NEJMoa1603702","journal-title":"N Engl J Med"},{"key":"4360_CR27","unstructured":"Becker JC et\u00a0al (2018) ASCO, S\u00a09527"},{"key":"4360_CR28","unstructured":"D\u2019Angelo SP et\u00a0al (2017) ASCO, S\u00a09530"},{"key":"4360_CR29","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40425-017-0310-x","volume":"6","author":"H Kaufman","year":"2018","unstructured":"Kaufman H et\u00a0al (2018) J\u00a0Immunother Cancer 6:7","journal-title":"J Immunother Cancer"},{"issue":"28","key":"4360_CR30","doi-asserted-by":"publisher","first-page":"26472","DOI":"10.18632\/oncotarget.4500","volume":"6","author":"MR Gaiser","year":"2015","unstructured":"Gaiser MR, Daily K, Hoffmann J, Brune M, Enk A, Brownell I (2015) Evaluating blood levels of neuron specific enolase, chromogranin A, and circulating tumor cells as Merkel cell carcinoma biomarkers. Oncotarget 6(28):26472\u201326482","journal-title":"Oncotarget"},{"key":"4360_CR31","doi-asserted-by":"crossref","unstructured":"Topalian SL et\u00a0al (2018) ASCO, S\u00a09505","DOI":"10.1200\/JCO.2018.36.15_suppl.9505"},{"issue":"8","key":"4360_CR32","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1002\/cncr.30475","volume":"123","author":"KG Paulson","year":"2017","unstructured":"Paulson KG, Lewis CW, Redman MW et\u00a0al (2017) Viral oncoprotein antibodies as a\u00a0marker for recurrence of Merkel cell carcinoma: a\u00a0prospective validation study. Cancer 123(8):1464\u20131474. https:\/\/doi.org\/10.1002\/cncr.30475","journal-title":"Cancer"},{"key":"4360_CR33","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-1184","author":"K Fan","year":"2018","unstructured":"Fan K, Ritter C, Nghiem P, Blom A, Verhaegen ME, Dlugosz A, Odum N, Woetmann A, Tothill RW, Hicks RJ, Sand M, Schrama D, Schadendorf D, Ugurel S, Becker JC (2018) Clin Cancer Res. https:\/\/doi.org\/10.1158\/1078-0432.CCR-18-1184","journal-title":"Clin Cancer Res"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-019-4360-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-019-4360-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-019-4360-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,25]],"date-time":"2020-11-25T08:23:12Z","timestamp":1606292592000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-019-4360-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,30]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["4360"],"URL":"https:\/\/doi.org\/10.1007\/s00105-019-4360-5","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,30]]},"assertion":[{"value":"30 January 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"C.\u00a0Drusio erhielt Reisekostenunterst\u00fctzung von Roche. J.C.\u00a0Becker erhielt Unterst\u00fctzung f\u00fcr Forschungsprojekte von Alcedis, Boehringer Ingelheim, BMS und Merck Serono. Honorare f\u00fcr Vortrags- und Beratert\u00e4tigkeit von Amgen, CureVac, eTheRNA, Lytix, Merck Serono, Novartis, Pfizer, Rigontec und Takeda sowie Reisekostenunterst\u00fctzung von 4SC und Incyte. D.\u00a0Schadendorf erhielt Unterst\u00fctzung f\u00fcr Forschungsprojekte von BMS, Novartis. Honorare f\u00fcr Vortrags- und Beratert\u00e4tigkeiten von Novartis, Roche, BMS, MSD, Amgen, Pfizer und Sanofi. S.\u00a0Ugurel erhielt Unterst\u00fctzung f\u00fcr Forschungsprojekte von BMS, medac und Merck Serono; Honorare f\u00fcr Vortrags- und Beratert\u00e4tigkeit von BMS, MSD, Roche, und Merck Serono sowie Reisekostenunterst\u00fctzung von BMS, medac, MSD und Roche.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Dieser Beitrag beinhaltet keine von den Autoren durchgef\u00fchrten Studien an Menschen oder Tieren. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patienten zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern eine schriftliche Einwilligung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}